165 related articles for article (PubMed ID: 36462680)
1. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma.
Sun J; Ding J; Shen Q; Wang X; Wang M; Huang Y; Zhang X; Zhu H; Zhang F; Wu D; Peng M; Zhang Z; Yuan Y; Li W; She ZG; Zhang XJ; Li H; Zhang P; Huang Z
J Hepatol; 2023 Mar; 78(3):627-642. PubMed ID: 36462680
[TBL] [Abstract][Full Text] [Related]
2. Identification of ALDH6A1 as a Potential Molecular Signature in Hepatocellular Carcinoma via Quantitative Profiling of the Mitochondrial Proteome.
Shin H; Cha HJ; Lee MJ; Na K; Park D; Kim CY; Han DH; Kim H; Paik YK
J Proteome Res; 2020 Apr; 19(4):1684-1695. PubMed ID: 31985234
[TBL] [Abstract][Full Text] [Related]
3. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
4. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
5. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
6. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.
Fujiwara N; Nakagawa H; Enooku K; Kudo Y; Hayata Y; Nakatsuka T; Tanaka Y; Tateishi R; Hikiba Y; Misumi K; Tanaka M; Hayashi A; Shibahara J; Fukayama M; Arita J; Hasegawa K; Hirschfield H; Hoshida Y; Hirata Y; Otsuka M; Tateishi K; Koike K
Gut; 2018 Aug; 67(8):1493-1504. PubMed ID: 29437870
[TBL] [Abstract][Full Text] [Related]
7. Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism.
Siliprandi N; Di Lisa F; Menabò R
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():11-5. PubMed ID: 2031869
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2.
Lu X; Zhang X; Zhang Y; Zhang K; Zhan C; Shi X; Li Y; Zhao J; Bai Y; Wang Y; Nie H; Li Y
Mol Carcinog; 2019 May; 58(5):749-759. PubMed ID: 30604893
[TBL] [Abstract][Full Text] [Related]
9. Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma.
Zhang J; Baddoo M; Han C; Strong MJ; Cvitanovic J; Moroz K; Dash S; Flemington EK; Wu T
Oncotarget; 2016 Aug; 7(31):49232-49245. PubMed ID: 27363021
[TBL] [Abstract][Full Text] [Related]
10. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.
Kowalik MA; Puliga E; Cabras L; Sulas P; Petrelli A; Perra A; Ledda-Columbano GM; Morandi A; Merlin S; Orrù C; Sanchez-Martin C; Fornari F; Gramantieri L; Parri M; Rasola A; Bellomo SE; Sebastian C; Follenzi A; Giordano S; Columbano A
J Hepatol; 2020 Jun; 72(6):1159-1169. PubMed ID: 31954205
[TBL] [Abstract][Full Text] [Related]
12. Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids.
Brass EP; Beyerinck RA
Biochem J; 1988 Mar; 250(3):819-25. PubMed ID: 3134008
[TBL] [Abstract][Full Text] [Related]
13. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
[TBL] [Abstract][Full Text] [Related]
14. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
15. OCTN2 enhances PGC-1α-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma.
Yang T; Liang N; Zhang J; Bai Y; Li Y; Zhao Z; Chen L; Yang M; Huang Q; Hu P; Wang Q; Zhang H
Metabolism; 2023 Oct; 147():155628. PubMed ID: 37315888
[TBL] [Abstract][Full Text] [Related]
16.
Li Y; Lin S; Li L; Tang Z; Hu Y; Ban X; Zeng T; Zhou Y; Zhu Y; Gao S; Deng W; Zhang X; Xie D; Yuan Y; Huang P; Li J; Cai Z; Guan XY
Cancer Res; 2018 Aug; 78(16):4471-4481. PubMed ID: 29967258
[TBL] [Abstract][Full Text] [Related]
17. L-propionyl-carnitine protection of mitochondria in ischemic rat hearts.
Di Lisa F; Menabò R; Siliprandi N
Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):169-73. PubMed ID: 2779536
[TBL] [Abstract][Full Text] [Related]
18. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
[TBL] [Abstract][Full Text] [Related]
19. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
